Iradimed (IRMD) Cash & Equivalents Growth (1y) (2014 - 2026)
Iradimed (IRMD) Cash & Equivalents Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -7.50% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -22.13% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -7.71% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.15% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 23.57% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 156.03% |
| 10 | Iradimed | 1.19 Bn | 1.13 Bn | 16.81 Mn | 12.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.01% |
| Dec 31, 2025 | -2.06% |
| Sep 30, 2025 | 9.29% |
| Jun 30, 2025 | 9.19% |
| Mar 31, 2025 | 11.53% |
| Dec 31, 2024 | 4.97% |
| Sep 30, 2024 | 10.64% |
| Jun 30, 2024 | 5.92% |
| Mar 31, 2024 | 5.49% |
| Dec 31, 2023 | -14.15% |
| Sep 30, 2023 | -15.91% |
| Jun 30, 2023 | -12.15% |
| Mar 31, 2023 | -15.20% |
| Dec 31, 2022 | -6.51% |
| Sep 30, 2022 | -4.76% |
| Jun 30, 2022 | -5.44% |
| Mar 31, 2022 | -0.70% |
| Dec 31, 2021 | 23.83% |
| Sep 30, 2021 | 22.76% |
| Jun 30, 2021 | 21.34% |